医学临床研究
   May. 6, 2025    Home  |  About Journal  |  Editorial Board  |  Instruction  |  Subscribe  |  Advertisement  |  Messages Board  |  Contact Us  |  中文
JOURNAL OF CLINICAL RESEARCH  2019, Vol. 36 Issue (3): 458-459    DOI: 10.3969/j.issn.1671-7171.2019.03.014
Current Issue | Archive | Adv Search |
Therapeutic Effect of Amphotericin B Inhalation in the Treatment of Oral Candidiasis in Patients with AIDS
WU Yong-feng, HUA Wei, ZHANG Yu-lin,et al
Beijing YouAn Hospital Affiliated Capital Medical University,BeiJing,100069,China
Download: PDF (0 KB)   HTML (1 KB) 
Export: BibTeX | EndNote (RIS)      
Abstract  【Objective】To investigate the efficacy and safety of amphotericin B inhalation in the treatment of HIV/AIDS patients with oral candidiasis. 【Methods】A total of 55 patients with HIV/AIDS and oral candidiasis admitted to Beijing You'an Hospital from June 2017 to June 2018 were enrolled. The amphotericin oxygen inhalation was used to observe the efficacy and adverse reactions. 【Results】The total effective rate of amphotericin B inhalation for treatment of HIV/AIDS with oral candidiasis was 96.4%. The incidence of adverse reaction like cough was 9.0%, and the incidence of nausea was 5.5%. However, both were tolerable. 【Conclusion】Amphotericin B inhalation is safe and effective in the treatment of oral candidiasis in patients with HIV/AIDS, which is worthy of clinical promotion.
Key wordsCandidiasis      Oral/CO      Acquired Immunodeficiency Syndrome/CO      Pharmaceutical Preparations     
Received: 23 December 2018     
PACS:  R512.91  
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
Cite this article:   
URL:  
http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2019.03.014     OR     http://journal07.magtech.org.cn/yxlcyj/EN/Y2019/V36/I3/458
Copyright © Editorial Board of JOURNAL OF CLINICAL RESEARCH
Supported by:Beijing Magtech